Menu
simpleWomen's HealthHealth EquityThematic Report

Femtech’s Challenge: Growth, Gaps, and the Health Equity Imperative

What if half the population’s health needs were an afterthought in global innovation—and what if fixing that presented a hundred-billion-dollar opportunity? Femtech is no longer just about fertility apps; it’s redefining how healthcare serves women across every stage of life. This report dives deep into the data behind the momentum, the money, and the massive market gaps that innovators and investors can no longer afford to ignore.

00_Femtechs Challenge

Femtech’s Challenge: Growth, Gaps, and the Health Equity Imperative

What if the untapped health needs of half the global population represented a $100B opportunity? Femtech is evolving from niche fertility tools into a powerful driver of inclusive innovation in healthcare. This comprehensive Femtech investment report explores the sector’s rapid evolution, spotlighting high-growth trends, persistent funding inequities, and the pressing need for health equity.

Backed by HealthTech Alpha—Galen Growth’s proprietary platform for global digital health data and market intelligence—this Femtech investment report delivers unmatched, non-hyped, data-driven insights across the ecosystem. From startup traction to investor dynamics, it’s an essential resource for those looking to understand where innovation is happening—and where it’s falling short.

Key Insights Include

  1. Femtech venture growth has surged 3.2x over the last decade, but investment lags at 1.4x growth.
  2. Femtech’s share of global digital health funding dropped to 7.6% in Q1 2025 from 14.7% in 2020.
  3. 70% of Femtech startups under six years old remain pre-Series A, highlighting a critical funding bottleneck.
  4. Health system partnerships now surpass pharma deals, accounting for 23% of Femtech collaborations.
  5. M&A is heating up, with 56% of deals occurring between startups, signaling early consolidation.

Ventures and Companies Covered in the Report

The “Femtech Challenge” report includes data on the following companies: Freya Biosciences, Millie, Allara, Orange Health, Oula, Flo Health, Freenome, BillionToOne, Koios Medical, Maven, Foodsmart, Sword Health, Eko Health, BillionToOne, Willow, RH Capital, Amboy Street Ventures, The Case for Her , Great Oaks Venture Capital, The Gates Foundation, GV, General Catalyst

Powered by HealthTech Alpha

Femtech’s Challenge: Growth, Gaps, and the Health Equity Imperative report is powered by HealthTech Alpha, the premier digital health intelligence platform delivering unparalleled data and insights into the evolving healthcare technology landscape. Leveraging an extensive database of over 15,000 ventures and cutting-edge analytics, HealthTech Alpha provides a data-driven foundation to analyse the critical trends shaping the future of digital health.

Designed to empower stakeholders—including investors, pharmaceutical leaders, and medical device manufacturers—HealthTech Alpha offers actionable intelligence to navigate digital transformation complexities. This collaboration ensures readers gain a comprehensive, evidence-based view of the intersection between digital health and healthcare, equipping them to identify strategic opportunities, assess market dynamics, and stay ahead in this fast-evolving industry.

Get the report

Use your company email address. Personal and disposable email services are not accepted.